DOWNLOAD
News – 1 August 2007
Thyrogen listed on PBS
The ATF is thrilled to advise that as of August 1st 2007, Thyrogen (thyrotropin alfa-rch) will be Authority listed on the PBS for the post-thyroidectomy remnant ablation indication.
This means that patients can have their surgery for thyroid cancer, go straight onto thyroxine, and then come back 2-4 weeks later to have their remnant ablation performed under Thyrogen stimulation, rather than having to become hypothyroid.
This will significantly improve the quality of life of patients and will also make it easier for doctors to schedule the radioiodine treatment.
The full details of the listing is as follows:
Authority required
Ablation of thyroid remnant tissue, in combination with radioactive iodine, in a post thyroidectomy adult aged 18 years or older without known metastatic disease. This drug is only PBS-subsidised for one treatment in a patient’s lifetime.